A Phase 3 Study to Evaluate the Safety and Efficacy

Project: Research project

Description

A Phase 3 Study to Evaluate the Safety and Efficacy of Tc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men with Biospy Proven Low-Grade Prostate Cancer who are Candidates for Active Surveillance
StatusFinished
Effective start/end date3/31/163/30/18

Funding

  • PROGENICS PHARMACEUTICALS, INC.

Fingerprint

Prostatic Neoplasms
Safety
Single Photon Emission Computed Tomography Computed Tomography